연구성과로 돌아가기
JCR 2024 저널 목록 (745 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Translation Studies | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | 1478-1700 | 1751-2921 | SSCI | LINGUISTICS | 737 | 1.2 | Q2 | 37.5 | 62.5 | 114/303 | 1.7 | Q2 | 1.0 | 0.2 | 0.75 | 147/303 | Q2 | 51.65 | 0.001 | 0.203 | 0.956 | Q1 | 16 | 100.0% | 12.5 | 11.7 | 16 | 31.5% | 2025-08-05 16:03:46 | 바로가기 |
| TROPICAL MEDICINE & INTERNATIONAL HEALTH | WILEY | 1360-2276 | 1365-3156 | SCIE | TROPICAL MEDICINE | 6,859 | 2.3 | Q2 | 37.5 | 62.5 | 11/28 | 2.6 | Q2 | 2.2 | 0.5 | 0.74 | 10/28 | Q2 | 66.07 | 0.004 | 0.921 | 0.801 | Q1 | 97 | 83.5% | 10.6 | 7.4 | 81 | 38.6% | 2025-08-05 16:05:28 | 바로가기 |
| URBAN AFFAIRS REVIEW | SAGE PUBLICATIONS INC | 1078-0874 | 1552-8332 | SSCI | URBAN STUDIES | 3,036 | 2.3 | Q2 | 37.5 | 62.5 | 29/76 | 2.9 | Q2 | 2.1 | 0.3 | 0.67 | 28/77 | Q2 | 64.29 | 0.003 | 0.638 | 1.061 | Q2 | 61 | 96.7% | 10.2 | 10.2 | 59 | 22.4% | 2025-08-05 16:05:29 | 바로가기 |
| VIAL-Vigo International Journal of Applied Linguistics | UNIV VIGO | 1697-0381 | N/A | SSCI | LINGUISTICS | 111 | 1.2 | Q2 | 37.5 | 62.5 | 114/303 | 1.2 | Q2 | 1.2 | 0.8 | 0.85 | 124/303 | Q2 | 59.24 | 0.000 | 0.019 | 0.330 | Q3 | 6 | 100.0% | 9.8 | 10.3 | 6 | 0.0% | 2025-08-05 16:03:47 | 바로가기 |
| Cancer Research Communications | AMER ASSOC CANCER RESEARCH | N/A | 2767-9764 | ESCI | ONCOLOGY | 1,416 | 3.3 | Q2 | 37.6 | 62.4 | 123/326 | 3.3 | Q2 | 3.2 | 0.8 | 0.75 | 130/326 | Q2 | 60.28 | 0.004 | 0.786 | 1.214 | Q2 | 247 | 100.0% | 1.8 | 7.2 | 247 | 94.2% | 2025-08-05 16:04:25 | 바로가기 |
| Clinical Lung Cancer | CIG MEDIA GROUP, LP | 1525-7304 | 1938-0690 | SCIE | ONCOLOGY | 4,508 | 3.3 | Q2 | 37.6 | 62.4 | 123/326 | 3.3 | Q2 | 3.2 | 0.8 | 0.78 | 124/326 | Q2 | 62.12 | 0.007 | 1.613 | 1.213 | Q2 | 144 | 93.8% | 5.2 | 5.2 | 135 | 17.7% | 2025-08-05 16:04:24 | 바로가기 |
| Current Hematologic Malignancy Reports | CURRENT MEDICINE GROUP | 1558-8211 | 1558-822X | SCIE | ONCOLOGY | 1,303 | 3.3 | Q2 | 37.6 | 62.4 | 123/326 | 2.9 | Q3 | 3.3 | 0.7 | 0.44 | 233/326 | Q3 | 28.68 | 0.002 | 0.410 | 1.028 | Q2 | 23 | 0.0% | 5.8 | 5.7 | 0 | 18.4% | 2025-08-05 16:04:25 | 바로가기 |
| Current Infectious Disease Reports | SPRINGER | 1523-3847 | 1534-3146 | SCIE | INFECTIOUS DISEASES | 1,639 | 2.9 | Q2 | 37.6 | 62.4 | 52/137 | 3.1 | Q2 | 2.8 | 0.6 | 0.43 | 100/137 | Q3 | 27.37 | 0.001 | 0.260 | 0.896 | Q2 | 23 | 0.0% | 7.9 | 7.0 | 0 | 25.3% | 2025-08-05 16:03:36 | 바로가기 |
| DRYING TECHNOLOGY | TAYLOR & FRANCIS INC | 0737-3937 | 1532-2300 | SCIE | ENGINEERING, MECHANICAL | 9,716 | 2.7 | Q2 | 37.6 | 62.4 | 69/182 | 3.4 | Q2 | 2.1 | 0.8 | 0.49 | 97/184 | Q3 | 47.55 | 0.003 | 0.717 | 0.415 | Q2 | 157 | 90.4% | 8.8 | 7.0 | 142 | 7.6% | 2025-08-05 16:03:10 | 바로가기 |
| FLOW MEASUREMENT AND INSTRUMENTATION | ELSEVIER SCI LTD | 0955-5986 | 1873-6998 | SCIE | ENGINEERING, MECHANICAL | 4,158 | 2.7 | Q2 | 37.6 | 62.4 | 69/182 | 2.5 | Q2 | 2.2 | 0.7 | 0.61 | 69/184 | Q2 | 62.77 | 0.002 | 0.454 | 0.338 | Q3 | 227 | 97.8% | 6.2 | 6.8 | 222 | 8.8% | 2025-08-05 16:03:10 | 바로가기 |
| Frontiers in Oncology | FRONTIERS MEDIA SA | 2234-943X | 2234-943X | SCIE | ONCOLOGY | 94,513 | 3.3 | Q2 | 37.6 | 62.4 | 123/326 | 3.8 | Q2 | 3.1 | 0.5 | 0.68 | 150/326 | Q2 | 54.14 | 0.158 | 35.139 | 0.912 | Q2 | 3414 | 78.8% | 3.3 | 5.9 | 2691 | 99.3% | 2025-08-05 16:04:23 | 바로가기 |
| Implementation Research and Practice | SAGE PUBLICATIONS INC | 2633-4895 | 2633-4895 | ESCI | HEALTH CARE SCIENCES & SERVICES | 586 | 2.6 | Q2 | 37.6 | 62.4 | 70/185 | 3.9 | Q2 | 2.5 | 0.5 | 0.88 | 66/185 | Q2 | 64.59 | 0.002 | 0.389 | 1.504 | Q1 | 24 | 100.0% | 3.3 | 7.4 | 24 | 96.2% | 2025-08-05 16:03:25 | 바로가기 |
| Infection and Chemotherapy | KOREAN SOC ANTIMICROBIAL THERAPY | 2093-2340 | 2092-6448 | ESCI | INFECTIOUS DISEASES | 1,405 | 2.9 | Q2 | 37.6 | 62.4 | 52/137 | 2.6 | Q3 | 2.6 | 1.0 | 0.64 | 71/137 | Q3 | 48.54 | 0.001 | 0.313 | 0.586 | Q3 | 48 | 91.7% | 4.8 | 6.3 | 44 | 95.4% | 2025-08-05 16:03:36 | 바로가기 |
| Infection and Drug Resistance | DOVE MEDICAL PRESS LTD | 1178-6973 | 1178-6973 | SCIE | INFECTIOUS DISEASES | 11,727 | 2.9 | Q2 | 37.6 | 62.4 | 52/137 | 3.5 | Q2 | 2.7 | 0.5 | 0.79 | 54/137 | Q2 | 60.95 | 0.016 | 3.617 | 0.749 | Q2 | 535 | 91.2% | 3.9 | 5.5 | 488 | 99.6% | 2025-08-05 16:03:36 | 바로가기 |
| Infection Control & Hospital Epidemiology | CAMBRIDGE UNIV PRESS | 0899-823X | 1559-6834 | SCIE | INFECTIOUS DISEASES | 10,225 | 2.9 | Q2 | 37.6 | 62.4 | 52/137 | 2.7 | Q2 | 2.5 | 0.5 | 0.86 | 42/137 | Q2 | 69.71 | 0.010 | 2.258 | 0.911 | Q2 | 177 | 98.9% | 8.2 | 5.7 | 175 | 41.8% | 2025-08-05 16:03:36 | 바로가기 |
페이지 이동: